Fall 2017 Newsletter

Follow our latest updates in our Newsletters and Annual Reports

Fall 2017 Newsletter
7th Residency Announcement

Exciting Residency Announcement!

ACGME approves seventh resident complement; first increase in over 30 years!

Grand Rounds

Grand Rounds and Case Studies

Check out our weekly presentations



USC Ophthalmology Researchers Find More
Effective Treatments For Blinding Eye Diseases


Case Study: You Give Me…

Haghighi Kashani
Presenter: Arezu Haghighi, MD Discussant: Amir Kashani, MD, PhD


  • 22-year-old male with history of retinal detachment repair OD as a 5-year-old child, seen for a second opinion regarding decreased vision in that eye since the surgery

Exam Findings

  • VA 20/100 OD with external examination only notable for focal lens opacity posteriorly at one o’clock
  • Dilated fundus exam notable for retinal fold extending superonasally from the disc as well as vascular dragging causing foveal displacement
Figure 1
Figure 1: Color fundus photo. A. OD showing retinal fold extending superonasally from the disc with vascular dragging and foveal displacement B. OS normal.


Differential Diagnosis

  • Familial exudative vitreoretinopathy (FEVR)
  • Retinopathy of Prematurity (ROP)
  • Persistent hyperplastic primary vitreous (PHPV)
  • Coat’s disease
  • Toxocariasis
  • High myopia
  • Retinoblastoma (Rb)

Additional Investigations

  • OCT macula showing outer retinal atrophy as well as inner retinal folds and distortion in the affected eye OD (see Figure 2), while OCT macula OS normal
Figure 2
Figure 2: A. OCT macula OD showing outer retinal atrophy as well as foveal distortion. B. OCT macula OS normal.



  • FEVR (Familial Exudative Vitreoretinopathy)


  • Driven by fibrovascular changes as a result of peripheral avascular retina with progression through five clinical stages
  • Associated with mutations in the Wnt pathway
  • Important to distinguish from ROP, as FEVR (no history of prematurity or low birth weight) can re-activate later in life while ROP has an involutional natural history
Figure 3
Figure 3: FEVR clinical staging.



  • Laser ablation of avascular retina in stage 1-2A disease; scleral buckle vs vitrectomy (lens-sparing vs non-lens sparing approach) for more advanced stages of disease
Figure 4
Figure 4: Fluorescein angiography findings in stage 2 FEVR: A. anomalous circumferential vessels B. expanded view C. supranumerary vascular branching D. expanded view E. disc leakage, macular aneurysms and bulb-like telangiectatic vascular endings.


Prognosis and Future Directions

  • Risk of re-activation and disease progression later on in life (has been observed up through the age of 40)
  • Importance of screening asymptomatic family members: study by Kashani et al., up to 58 percent of asymptomatic family members had stage 1 or 2 FEVR and 21 percent had stage 3, 4, or 5 FEVR
  • Screening most effectively done through fluorescein angiography to detect early stage 2 changes (see Figure 4)


  • Trese MT, Kashani AH. Advances in the diagnosis, management and pathophysiology of capillary nonperfusion. Expert Rev Ophthalmol. 2012;7(3):281-292.
  • Kashani AH, et al. High Prevalence of Peripheral Retinal Vascular Anomalies in Family Members of Patients with Familial Exudative Vitreoretinopathy. Ophthalmology. 2014 Jan;121(1):262-268.
  • Kashani AH, et al. Diversity of Retinal Vascular Anomalies in Patients with Familial Exudative Vitreoretinopathy. Ophthalmology. 2014 Nov;121(11):2220-7.
  • Pendergast SD, Trese MT. Familial Exudative Vitreoretinopathy. Results of Surgical Management. Ophthalmology. 1998 Jun;105(6):1015-23.
  • Ranchod TM, et al. Clinical Presentation of Familial Exudative Vitreoretinopathy. Ophthalmology. 2011 Oct;118(10):2070-5.
  • The International Classification of Retinopathy of Prematurity Revisited. Arch Ophthalmol. 2005;123(7):991-999.
  • Jeng-Miller KW, et al. Fluorescein Angiography in Persistent Fetal Vasculature. Ophthalmol. 2017 Apr;124(4):455.z
  • Shastry BS. Persistent hyperplastic primary vitreous: congenital malformation of the eye. Clin Exp Ophthalmol. 2009 Dec;37(9):884-90.


Section Editors


Produced by: Monica Chavez, John Daniel, Joseph Yim and Dr. Vivek Patel
Scroll Up To Top

USC Roski Eye Institute

1450 San Pablo St., 4th Floor,
Los Angeles, CA 90033

USC Roski Eye Institute

65 N. First Ave., Suite 101,
Arcadia, CA 91006

USC Roski Eye Institute

625 S. Fair Oaks Ave., Suite 400,
Pasadena, CA 91105

USC Roski Eye Institute
USC Village

835 W. Jefferson Blvd., Suite 1720
Los Angeles, CA 90089

Children’s Hospital
Los Angeles

4650 Sunset Blvd.,
Los Angeles, CA 90027

View Full Desktop Version

Coronavirus (COVID-19) Announcement

Due to ongoing developments with COVID-19, we are only able to see patients with urgent eye problems at this time. If you have any questions or concerns, please call us at 323-442-6335.